Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health Opportunities and Promoters of Equitable Screening for Lung Cancer (HOPES for Lung Cancer)

NCT05784922 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05784922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05784922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health Opportunities and Promoters of Equitable Screening for Lung Cancer (HOPES for Lung Cancer)
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 3, 2023
Completion date
January 31, 2028
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis, lung cancer, smoking behaviors